Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2024 Earnings Call Transcript

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2024 Earnings Call Transcript February 27, 2025

Amphastar Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.92 EPS, expectations were $1.01.

Operator: Greetings and welcome to the Amphastar Pharmaceuticals Fourth Quarter Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note that certain statements...